Shanghai Fosun High Technology (Group) Co., Ltd. - Net Worth and Insider Trading

Shanghai Fosun High Technology (Group) Co., Ltd. Net Worth

The estimated net worth of Shanghai Fosun High Technology (Group) Co., Ltd. is at least $874 Million dollars as of 2024-09-23. Shanghai Fosun High Technology (Group) Co., Ltd. is the of Shanghai Fosun Pharmaceutical (Group) Co Ltd and owns about 71,533,500 shares of Shanghai Fosun Pharmaceutical (Group) Co Ltd (HKSE:02196) stock worth over $874 Million. Details can be seen in Shanghai Fosun High Technology (Group) Co., Ltd.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Shanghai Fosun High Technology (Group) Co., Ltd. has not made any transactions after 2021-06-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Shanghai Fosun High Technology (Group) Co., Ltd.

Shanghai Fosun High Technology (Group) Co., Ltd. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Shanghai Fosun High Technology (Group) Co., Ltd. owns 1 companies in total, including Shanghai Fosun Pharmaceutical (Group) Co Ltd (HKSE:02196) .

Click here to see the complete history of Shanghai Fosun High Technology (Group) Co., Ltd.’s form 4 insider trades.

Insider Ownership Summary of Shanghai Fosun High Technology (Group) Co., Ltd.

Ticker	Comapny	Transaction Date	Type of Owner
HKSE:02196	Shanghai Fosun Pharmaceutical (Group) Co Ltd	2021-06-30

Shanghai Fosun High Technology (Group) Co., Ltd. Latest Holdings Summary

Shanghai Fosun High Technology (Group) Co., Ltd. currently owns a total of 1 stock. Shanghai Fosun High Technology (Group) Co., Ltd. owns 71,533,500 shares of Shanghai Fosun Pharmaceutical (Group) Co Ltd (HKSE:02196) as of June 30, 2021, with a value of $874 Million.

Latest Holdings of Shanghai Fosun High Technology (Group) Co., Ltd.

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:02196	Shanghai Fosun Pharmaceutical (Group) Co Ltd	2021-06-30	71,533,500	12.22	874,139,370

Holding Weightings of Shanghai Fosun High Technology (Group) Co., Ltd.

Shanghai Fosun High Technology (Group) Co., Ltd. Form 4 Trading Tracker

According to the SEC Form 4 filings, Shanghai Fosun High Technology (Group) Co., Ltd. has made a total of 1 transactions in Shanghai Fosun Pharmaceutical (Group) Co Ltd (HKSE:02196) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Shanghai Fosun Pharmaceutical (Group) Co Ltd is the sale of 0 shares on June 30, 2021, which brought Shanghai Fosun High Technology (Group) Co., Ltd. around $0.

Insider Trading History of Shanghai Fosun High Technology (Group) Co., Ltd.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Shanghai Fosun High Technology (Group) Co., Ltd. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Shanghai Fosun High Technology (Group) Co., Ltd. Ownership Network

Ownership Network List of Shanghai Fosun High Technology (Group) Co., Ltd.

No Data

Ownership Network Relation of Shanghai Fosun High Technology (Group) Co., Ltd.

Shanghai Fosun High Technology (Group) Co., Ltd. Owned Company Details

What does Shanghai Fosun Pharmaceutical (Group) Co Ltd do?

Who are the key executives at Shanghai Fosun Pharmaceutical (Group) Co Ltd?

Shanghai Fosun High Technology (Group) Co., Ltd. is the of Shanghai Fosun Pharmaceutical (Group) Co Ltd. Other key executives at Shanghai Fosun Pharmaceutical (Group) Co Ltd include 2201 Interest of corporation controlled by you BlackRock, Inc. , Jpmorgan Chase & Co. , and 2201 Interest of corporation controlled by you Fosun International Holdings Ltd. .

Shanghai Fosun Pharmaceutical (Group) Co Ltd (HKSE:02196) Insider Trades Summary

Over the past 18 months, Shanghai Fosun High Technology (Group) Co., Ltd. made no insider transaction in Shanghai Fosun Pharmaceutical (Group) Co Ltd (HKSE:02196). Other recent insider transactions involving Shanghai Fosun Pharmaceutical (Group) Co Ltd (HKSE:02196) include a net purchase of 2,574,607 shares made by BlackRock, Inc. ,

In summary, during the past 3 months, insiders sold 0 shares of Shanghai Fosun Pharmaceutical (Group) Co Ltd (HKSE:02196) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Shanghai Fosun Pharmaceutical (Group) Co Ltd (HKSE:02196) were sold and 2,574,607 shares were bought by its insiders, resulting in a net purchase of 2,574,607 shares.

Shanghai Fosun Pharmaceutical (Group) Co Ltd (HKSE:02196)'s detailed insider trading history can be found in Insider Trading Tracker table.

Shanghai Fosun Pharmaceutical (Group) Co Ltd Insider Transactions

No Available Data

Shanghai Fosun High Technology (Group) Co., Ltd. Mailing Address

Above is the net worth, insider trading, and ownership report for Shanghai Fosun High Technology (Group) Co., Ltd.. Currently GuruFocus does not have mailing address information for Shanghai Fosun High Technology (Group) Co., Ltd..

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.